[Form 4] ROPER TECHNOLOGIES INC Insider Trading Activity

Rhea-AI Filing Summary

Archambeau Shellye L, a director of Roper Technologies, acquired 64 restricted shares of ROPER TECHNOLOGIES INC (ROP) on 09/15/2025 at $0 under the company's Director Compensation Plan, increasing her beneficial ownership to 8,194 shares. The restricted shares vest on the six-month anniversary of the grant date, as disclosed in the filing. The Form 4 was signed by an attorney-in-fact on 09/17/2025. The filing reports a routine equity grant to a director and specifies the vesting condition but does not include additional financial terms or valuation details.

Positive

• Director received equity (64 restricted shares), which aligns management and shareholder interests
• Vesting condition disclosed: shares vest on the six-month anniversary, supporting retention and alignment

Negative

• None.

Insights

Financial Analyst

TL;DR: A routine director equity grant of 64 restricted shares increases insider alignment without material balance-sheet impact.

The transaction is a small, tax-advantaged compensation award typical for non-employee directors. The grant size (64 shares) and zero cash price indicate restricted stock issued as compensation rather than an open-market purchase. Beneficial ownership after the grant is 8,194 shares, and the six-month vesting schedule limits immediate liquidity. For most investors, this disclosure is informational and not financially material to company valuation.

Corporate Governance Expert

TL;DR: Director received restricted shares under the standard compensation plan with a six-month vesting condition; governance signal is neutral.

The grant aligns the director's interests with shareholders by increasing equity stake, and the restricted-vesting structure supports retention. The filing clearly states the award stems from the Director Compensation Plan and the vesting timeline. There are no disclosures of accelerated vesting, transfers, or related-party arrangements in this document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ARCHAMBEAU SHELLYE L

(Last) (First) (Middle)

C/O ROPER TECHNOLOGIES, INC.

6496 UNIVERSITY PARKWAY

(Street)

SARASOTA FL 34240

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ROPER TECHNOLOGIES INC [ ROP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		A		64(1)	A	$0	8,194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The securities reported are restricted shares granted to the reporting person pursuant to the Director Compensation Plan. The restricted shares vest on the 6-month anniversary of the grant date.

	/s/ John K. Stipancich, Attorney-in-fact	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ROP director Archambeau Shellye L report on Form 4?

The director reported acquiring 64 restricted shares of ROPER TECHNOLOGIES INC (ROP) on 09/15/2025, increasing beneficial ownership to 8,194 shares.

What was the price for the shares reported in the ROP Form 4?

The reported price for the restricted shares was $0, indicating they were granted as compensation under the Director Compensation Plan.

When do the restricted shares reported by the ROP director vest?

The restricted shares vest on the six-month anniversary of the grant date, as stated in the filing.

Who signed the Form 4 for Archambeau Shellye L and when?

The Form 4 was signed by John K. Stipancich, Attorney-in-fact on 09/17/2025.

Does the Form 4 disclose any sale or market purchase by the director?

No. The filing discloses an acquisition of restricted shares; there is no sale or open-market purchase reported.